According to Zacks, “Shares of Adtalem have witnessed a sharp decline in a year’s time. The company has been witnessing tepid enrolment growth at its institutions, as improving employment situation is hampering the growth prospects of for-profit education companies. Additionally, it has been experiencing restructuring charges related to closing of the Ross University School of Medicine campus in Dominica and real estate consolidations. Nonetheless, Adtalem has been undertaking initiatives for achieving strong multi-year organic growth. Its cost-saving initiatives, transformation strategy and continued focus on stackable programs that are aligned with key growth areas should drive growth. Earnings estimates for the current quarter and fiscal year have remained stable over the past 60 days.”
A number of other brokerages have also weighed in on ATGE. Barrington Research reaffirmed a buy rating and issued a $62.00 price target on shares of Adtalem Global Education in a research note on Wednesday, January 9th. ValuEngine lowered shares of Adtalem Global Education from a buy rating to a hold rating in a research note on Thursday, March 7th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of Buy and a consensus target price of $58.60.
Adtalem Global Education stock opened at $47.67 on Monday. The company has a quick ratio of 2.07, a current ratio of 2.07 and a debt-to-equity ratio of 0.20. The stock has a market cap of $2.77 billion, a price-to-earnings ratio of 17.15, a PEG ratio of 1.27 and a beta of 0.84. Adtalem Global Education has a 52-week low of $43.50 and a 52-week high of $58.80.
Adtalem Global Education (NYSE:ATGE) last posted its earnings results on Thursday, February 7th. The company reported $0.74 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.74. The firm had revenue of $316.60 million during the quarter, compared to analyst estimates of $318.95 million. Adtalem Global Education had a net margin of 8.70% and a return on equity of 11.41%. Adtalem Global Education’s revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.76 EPS. Equities analysts forecast that Adtalem Global Education will post 2.86 EPS for the current fiscal year.
In other news, Director James D. White sold 2,936 shares of the company’s stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $49.03, for a total value of $143,952.08. Following the completion of the sale, the director now owns 6,523 shares in the company, valued at $319,822.69. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Carlos Filgueiras sold 3,205 shares of the company’s stock in a transaction on Wednesday, February 13th. The shares were sold at an average price of $48.22, for a total value of $154,545.10. Following the completion of the sale, the insider now owns 11,775 shares of the company’s stock, valued at approximately $567,790.50. The disclosure for this sale can be found here. Corporate insiders own 1.91% of the company’s stock.
Several institutional investors have recently made changes to their positions in the company. Penserra Capital Management LLC acquired a new stake in Adtalem Global Education during the fourth quarter valued at approximately $28,000. Fort L.P. acquired a new stake in Adtalem Global Education during the fourth quarter valued at approximately $54,000. Enlightenment Research LLC acquired a new stake in Adtalem Global Education during the fourth quarter valued at approximately $76,000. Bank of Montreal Can lifted its stake in Adtalem Global Education by 17.8% during the fourth quarter. Bank of Montreal Can now owns 2,681 shares of the company’s stock valued at $126,000 after purchasing an additional 405 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in Adtalem Global Education by 772.5% during the third quarter. Tower Research Capital LLC TRC now owns 2,792 shares of the company’s stock valued at $134,000 after purchasing an additional 2,472 shares during the last quarter. Institutional investors and hedge funds own 96.24% of the company’s stock.
Adtalem Global Education Company Profile
Adtalem Global Education Inc provides educational services worldwide. It operates through three segments: Medical and Healthcare, Professional Education, and Technology and Business. The Medical and Healthcare segment operates Chamberlain University, which provides a pre-licensure bachelor's degree in nursing at 21 campus locations and post-licensure bachelor's, master's, and doctorate degree programs in nursing through its online platform; and operates medical and veterinary schools, including American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
See Also: What is Green Investing?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.